Mechanism of Action Trial of ColoAd1

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2016

Conditions

Resectable Colon CancerResectable Non-small Cell Lung CancerResectable Bladder CancerResectable Renal Cell Carcinoma

Interventions

BIOLOGICAL

Colo-Ad1

Oncolytic virus

Trial Locations (2)

Hospital Universitario Madrid Sanchinarro CIOCC, Madrid

Hospital Universitario Virgen del Rocío, Seville